Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-23T01:51:08.955Z Has data issue: false hasContentIssue false
  • English
  • Français

Carbon monoxide poisoning and neuroleptic malignant syndrome

Published online by Cambridge University Press:  13 June 2014

Judith M V Allen  and
Clare E Monaghan
Clare E Monaghan
Affiliation:
St. Luke's Hospital, Loughgall Road, Armagh, Co Armagh, Northern Ireland
Get access Rights & Permissions [Opens in a new window]

Abstract

We report a case of carbon monoxide poisoning where symptoms of Neuroleptic Malignant Syndrome developed following use of neuroleptic medication. Literature review has failed to reveal a previous report of neuroleptic malignant syndrome following carbon monoxide insult.

Keywords

Neuroleptic malignant syndromeCarbon monoxide poisoningBasal ganglia
Type
Clinical & Brief Reports
Information
Irish Journal of Psychological Medicine , Volume 10 , Issue 3 , October 1993 , pp. 155 - 156
Copyright
Copyright © Cambridge University Press 1993

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Adityanjee, , Singh, S, Singh, G. Spectrum concept of neuroleptic malignant syndrome. Br J Psychiatry 1988; 153: 107–11.CrossRefGoogle ScholarPubMed
2.Fogel, BS, Goldberg, RJ. Neuroleptic malignant syndrome [letter]. New Eng J Med 1985; 313: 1292.Google Scholar
3.Velamoor, VR, Fernando, MLD, Williamson, P. Incipient neuroleptic malignant syndrome. Br J Psychiatry 1990; 156: 581–4.CrossRefGoogle ScholarPubMed
4.Levenson, JL. Neuroleptic malignant syndrome. Am J Psychiatry 1985; 142: 1137–45.Google ScholarPubMed
5.Lishman, WA. Organic psychiatry. 2nd Ed. Oxford: Blackwell, 1987: 469–72.Google Scholar
6.Kellham, AMP. The (frequently) neuroleptic (potentially) malignant syndrome. Br J Psychiatry 1990; 147: 169–73.CrossRefGoogle Scholar
7.Itoh, H, Ohtsuka, N, Ogita, K, Yogi, G, Miura, S, Koga, Y. Malignant neuroleptic syndrome. Its present status in Japan and clinical problems. Folia Psychiatrica et Neurologica Japonica 1977; 31: 565–76.Google ScholarPubMed
8.Hamburg, P, Weilburg, J B, Cassem, NH, et al.Relapse of neuroleptic malignant syndrome with early discontinuation of amantadine therapy. Compr Psychiatry 1986; 27: 272–8.CrossRefGoogle ScholarPubMed
9.Burke, RE, Fahn, S, Mayeux, R, Weinberg, H, Louis, K, Willner, J. Neuroleptic malignant syndrome caused by dopamine depleting drugs in a patient with Huntington's disease. Neurology 1981; 31: 1022–6.CrossRefGoogle Scholar
10.Dalkin, T, Lee, AS. Carbamazepine and forme fruste neuroleptic malignant syndrome. Br J Psychiatry 1990; 157: 437–8.CrossRefGoogle ScholarPubMed
11.Caroft, SN. The neuroleptic malignant syndrome. J Clin Psychiatry 1980; 41: 79–83.Google Scholar
12.Serby, M. Neuroleptic malignant syndrome in Alzheimer's disease. J Am Geriatr Soc 1986; 34: 895–6.CrossRefGoogle ScholarPubMed
13.Konikoff, F, Kuritzky, A, Jerushalmi, Y, Theodor, E. Neuroleptic malignant syndrome induced by a single injection of haloperidol. BMJ 1984; 289: 1228–9.CrossRefGoogle ScholarPubMed
14.Szabadi, E. Neuroleptic malignant syndrome [Editorial]. BMJ 1984; 288: 1399–400.CrossRefGoogle ScholarPubMed